GlassScriptPhysician profile
Madysen Weigel
NPI 1295492908
$3,094.17
in general payments reported to CMS, 2019-2025
19 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.31 · 2022: $285 · 2023: $686 · 2024: $1,036 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,260 · Education: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,259.93 |
| Education | $496.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $629.14 | 2022-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $508.17 | 2022-2025 | Ilumya, Blu-U, Winlevi |
| Abbvie INC. | $398.69 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $388.21 | 2022-2025 | Sotyktu |
| Amgen INC. | $193.18 | 2022-2025 | Otezla, Otezla |
| Ucb, INC. | $182.17 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $171.86 | 2022-2025 | |
| Pfizer INC. | $160.73 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $96.09 | 2024 | Dupixent |
| Sanofi-Aventis U.S. LLC | $85.00 | 2025 | |
| Organon LLC | $69.47 | 2023-2024 | |
| Leo Pharma INC. | $55.88 | 2023 | Adbry |
| Genzyme Corporation | $33.57 | 2021-2022 | |
| Lilly USA, LLC | $28.32 | 2022 | |
| Biowound Solutions, INC. | $26.61 | 2025 | Bio-Connekt |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.46 | 2025 | Spevigo |
| Smith+Nephew, INC. | $17.82 | 2021 | |
| Incyte Corporation | $16.49 | 2021 | |
| Genentech USA, INC. | $14.31 | 2024 | Erivedge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madysen Weigel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.